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Abstract session 1
1. Predictors of cardio pulmonary resuscitation
outcome in post-operative cardiac children
B. Nasser
PSCCQ, Buridha, Saudi Arabia
Outcome of cardiopulmonary resuscitation (CPR) in
children with congenital heart disease has improved and
many children survived after in hospital cardiac arrestthe
purpose of this study is to determine predictor of poor out-
come after CPR in critical children undergoing cardiac
surgerywe conducted a retrospective chart review and
data analysis of all CPR records and charts of all post-
operative cardiac children who had cardiac arrest and
required resuscitation from 2012 till 2015. Demographic,
pre-operative data were reviewed and analyzed during
study period 18 post-operative pediatric cardiac patients
had CPR. Nine of them had return of spontaneous circula-
tion (ROSC) and survived (50%). On average CPR was
required on the 3rd postoperative day. Univariate analysis
demonstrated that poor outcome was associated with
higher lactic acid measured 4–6 h prior to arrest
(P = 0.045) (P = 0.02) coupled with higher heart rate
(P = 0.031), lower O2 saturation (P = 0.01) and lower core
body temperature (P = 0.019) record 6 h before arrest.
Non-survival required longer resuscitation duration and
more epinephrine doses (P < 0.05) higher heart rate, lower
core body temperature , lower O2 saturation and higher
lactic acid measured 6 h before arrest are possible predic-
tors of poorer outcome and mortality following CPR in
post-operative cardiac children.
http://dx.doi:10.1016/j.jsha.2016.04.002
2. Minimally invasive mitral valve surgery why do
you take the risks?
A. Attia a, F. Oueida b, K. Alkhamees b
K. Eskander b, M. Alrefaei c, H. Ammar b
a Saud Al-Babtain Cardiac Centre, Dammam, Saudi
Arabia; b Saud Al-Babtain Cardiac Centre, Cardiac
Surgery, Dammam, Saudi Arabia; c Saud Al-Babtain
Cardiac Centre, Cardiology, Dammam, Saudi Arabia
During recent years, minimally invasivemitral valve sur-
gery (MIMVS) become the preferredmethod of mitral valve
repair and replacement inmany institutionsworldwidewith
excellent results, in spite of there isnocleardifinitionofmini-
mally invasive surgery and we do not have efficient studies
about the risks of MIMVS comparing to conventional mitral
valve surgery. Many studies are needed to clarify the need
for either conventional or minimally invasive mitral valve
surgery instead of personal preference. The patient’s demo-
graphic profile, intraoperative data and postoperative out-
comes of patients undergoing minimally invasive mitral
valve surgery were retrospectively collected from our data-
base from May 2011 to April 2014. We will present early
and mid-term outcomes of patients undergoing minimally
invasivemitral valve surgery in our institution. Seventy con-
secutive patients (45 male and 25 female), age 35 ± 12 years,
underwent MIMVS surgery. Mean preoperative New York
Heart Association function class was 2.6 ± 0.7.Mean ejection
fraction was 50 ± 8. Cardiopulmonary bypass was instituted
through femoral cannulation (28 of 70, 40%), or direct aortic
cannulation (42 of 70, 25%). Aortic cross-clamp used in (66
of 70, 94.2%). Without aortic cross-clamp in (4 of 70, 5.7%),
mitral valve repair has been done in (52 of 70, 74.2%), mitral
valve replacement (18 of 70, 25.7%). Concomitant procedures
included AF ablation (24 of 70, 34.2%), and tricuspid valve
repair (33of 70, 47.1%).Nomortality recorded, residualmitral
regurge was found in (6 of 70, 8.5%) during 1 year follow up.
Cardiopulmonary bypass, and ‘‘skin to skin’’ surgery were
95 ± 35 and 250 ± 74 min, respectively. 4 patients (5.7%)
underwent reexploration for bleeding and (57 of 70, 81.4%)
did not receive any blood transfusions. Six patients (8.5%)
sustained face oedema. Mean length of hospital stay was
7 ± 3.8 days. 18 patients (25.7%) did not feel any interest
regarding cosmotic advantage over conventional surgery.
Minimally invasivemitral valve surgery is an excellent alter-
native to conventional mitral valve surgery in most cases
however comparing to conventional mitral surgery it shows
long bypass time, long cross clamp time, difficult reexplora-
tion for bleeding and multiple body incisions.
http://dx.doi:10.1016/j.jsha.2016.04.003
3. Early outcomes of minimally invasive versus
conventional mitral valve surgery in mitral valve
diseases. A single institutional experience
E. Nourelden a, W. Abu Khudair b, M. Alnajjar c,
A. Arnous b
aKing Fahd Armed Force Hospital, Jeddah, Saudi
Arabia;
bKing Fahd Armed Force Hospital, Cardiac Surgery,
Jeddah, Saudi Arabia; cKing Fahd Armed Force Hospi-
tal, CCU, Jeddah, Saudi Arabia
Minimally invasive techniques in cardiac surgery
gained popularity due to many advantages like less post-
operative pain, minimal blood loss, less hospital stay, less
cost. Minimally invasive mitral valve surgery through
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